Effect of a 3-Week Treatment with GLP-1 Receptor Agonists on Vasoactive Hormones in Euvolemic Participants.
J Clin Endocrinol Metab
; 107(6): e2581-e2589, 2022 05 17.
Article
in En
| MEDLINE
| ID: mdl-35134170
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Glucagon-Like Peptide-1 Receptor
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
J Clin Endocrinol Metab
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: